Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion type Assertion NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_head.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion description "[In lymph node-positive patients a trend between high TA1 reactivity and a worse overall survival was also noted (log rank P = 0.128; Wilcoxon P = 0.054), with a 6-year survival of 42% in the strongly reactive tumors (n = 16) and 65% in the negative to weakly reactive carcinomas (n = 105).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_provenance.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion evidence source_evidence_literature NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_provenance.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion SIO_000772 2573426 NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_provenance.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion wasDerivedFrom befree-20140225 NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_provenance.
- NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_assertion wasGeneratedBy ECO_0000203 NP920920.RAwDoSZ19t-iAHvojGVzWGUnpCSMC9MWAsv9NDOFxYgnY130_provenance.